The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Health innovations are viewed more positively than food and agricultural technologies
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Subscribe To Our Newsletter & Stay Updated
